APP and Alzheimer disease: Concomitantly, in AD mice, EGCG attenuated the reduction in α-secretase expression and the increase in β-secretase and Aβ that AD causes in the brain, suggesting that memory dysfunction was prevented by changes in APP processing (Lee et al., 2009).